glp 1 weight loss oral solution does it work A New Option in Management A new once-daily GLP-1, orforglipron (Foundayo™) was FDA approved on April 1, 2026 ATTAIN-1 Trial: ~12.4% average weight (~27 lbs) and Improved cholesterol + Foundayo (Orforglipron) for Weight Loss:

Scott Harris, M.D., will be discussing the promise of #GLP1/#Glucagon approaches in treating #MASH and #MASLD, as well as the importance of developing therapies tailored to the specific needs of patients with #obesity and/or #MASH

A recent study links use of weight-loss drugs like Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, or Zepbound to vision loss in patients.

'(Semaglutide)'

The fermentation of fiber in the gut leads to the production of short-chain fatty acids, which can stimulate GLP-1 secretion

Thats where fiber becomes essential

GLP-1R Agonist Evolution: From Diabetes to Weight Loss | Peptidic GLP-1R agonists have received significant media coverage over the past year for their astounding efficacy in several indications